Alcohol Use Disorder
Alcohol Use Disorder (AUD), commonly known as alcoholism, is characterized by uncontrolled drinking and a preoccupation with alcohol, continuing despite significant negative consequences and evidence of dependence and withdrawal symptoms. According to the World Health Organization, as of 2016, around 283 million people globally were affected by this condition.
Health Outcomes
- Alleviated Alcohol-Induced Gastric Ulcers
- Altered Neurobiological Markers
- Altered Pyridoxine Concentration
- Attenuation of Health Effects After Cessation
- Changed Magnesium Level
- Enhanced Detoxification
- Improved Alcohol Metabolism
- Improved Alcohol-Related Neuropsychiatric Symptoms
- Improved Alcohol-induced Liver Injury
- Improved Consumer Acceptance
- Improved Detoxification
- Improved Enzyme Levels (ADH, ALDH)
- Improved General Health
- Improved Immune Function Post-Cessation
- Improved Liver Antioxidant Capacity
- Improved Liver Function (γ-glutamyltranspeptidase)
- Improved Psychosocial Domain Score
- Improved Safe Consumption Practices
- Improved Seizure Control
- Improved Semen Quality
- Improved Serum Albumin Levels
- Improved Treatment Success
- Increased ALDH Levels
- Increased Alcohol Dehydrogenase Levels in Liver
- Increased Anion Gap
- Increased Days Abstinent
- Increased High-Density Lipoprotein Levels
- Increased Jejunal Permeability
- Increased Liver Alcohol Metabolizing Enzyme Activity
- Increased Mean Corpuscular Hemoglobin
- Increased Nausea
- Increased Negative Transcriptional Regulation
- Increased Production of Acetate
- Increased Safety
- Increased Thiamine Diphosphate Level
- Increased β-glucosidase Levels
- Lapse in Effect Post-Cessation
- No CYP1A2 or CYP3A4 Interaction
- No Change in Objective Stress Markers
- No Long-Term Impact on Gut Microbiota
- No Significant Change in Health Variables
- No Significant Difference Compared to Placebo
- Prevented Exacerbation of Thiamine Deficiency
- Prevented Production of Harmful Substances
- Prevention of Alcoholic Liver Disease
- Reduced Acute Liver Injury
- Reduced Acute Pancreatitis Severity
- Reduced Alcohol Consumption
- Reduced Alcohol-Induced Liver Inflammation
- Reduced Alcohol-Induced Liver Lipid Accumulation
- Reduced Alcohol-Induced Liver Oxidative Stress
- Reduced Alcohol-Related Gut Microbiome Dysbiosis
- Reduced Automaticity of Drinking
- Reduced Cancer Mortality
- Reduced Common Cold Incidence
- Reduced Composite Score
- Reduced Cost-Effectiveness in Reducing AAD
- Reduced Craving
- Reduced Drinking Obsessions
- Reduced Folate Deficiency
- Reduced Heavy Drinking Day
- Reduced Incidence of Liver Cancer
- Reduced Interference Due to Drinking
- Reduced Luteinizing Hormone Level
- Reduced NREM Sleep Quality
- Reduced Red Blood Cell Folate Concentration
- Reduced Relapse Rate
- Reduced Sperm Motility
- Reduced Total Testosterone Level
- Reduced Undesirable Compounds
- Reduced Wernicke Encephalopathy Symptoms
- Resolved Keratomalacia
- Safety for Consumption
- Safety of Consumption
- Sustained Effects with Ongoing Consumption